Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › IL › Rockford › NPI 1356451546
Physician

Soufan, Bassam

Soufan, Bassam was paid $575K by Medicaid between Jan 2018 and Dec 2024, across 10 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 73% of everything it billed.

33Billing provider infoSOUFAN, BASSAM
ROCKFORD, IL 61114
33aNPI1356451546assigned 08/30/2006
28Total paid$575K
24GClaims10,001
24DCodes billed10
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Family Medicine Physician providers in Illinois

Rank by total paid#179 of 2,947
Median peer was paid$43K
This provider vs. median13×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$10K$20K$30K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
20181,469$90K
20193,511$203K
20201,565$93K
2021813$45K
20221,218$70K
2023699$32K
2024incomplete726$42K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 73% 6,617 6,114 $418K
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 13% 1,563 1,480 $72K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 5.5% 709 683 $31K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 4.0% 335 327 $23K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 2.8% 301 289 $16K
87811 Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) 1.2% 178 166 $7K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 100 57 $5K
87634 <1% 25 25 $1K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) <1% 12 12 $1K
81003 <1% 161 157 $337.90

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.